We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.77%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.23B
AUM Growth
-$162M
(-4.8%)
Cap. Flow
-$213M
Cap. Flow
% of AUM
-6.6%
Top 10 Holdings %
Top 10 Hldgs %
19.05%
Holding
1,571
New
110
Increased
706
Reduced
485
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$38.9M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$34M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$14.7M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$13.2M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$101M |
| 2 |
BCS.PRD.CL
Barclays Bank Plc
BCS.PRD.CL
|
+$45.7M |
| 3 |
Fidelity MSCI Consumer Staples Index ETF
FSTA
|
+$34.6M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$33M |
| 5 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.3% |
| 2 | Technology | 5.26% |
| 3 | Energy | 5.22% |
| 4 | Healthcare | 4.79% |
| 5 | Industrials | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
RTX Corp
RTX
$302B
| $5.15M | 0.16% |
71,171
+3,046
| +4% | +$208K |
|
127
Eli Lilly
LLY
$1.1T
| $5.1M | 0.16% |
73,959
+2,225
| +3% | +$150K |
|
|
CELG
128
DELISTED
Celgene Corp
CELG
| $5.09M | 0.16% |
45,472
+2,581
| +6% | +$272K |
|
129
Qualcomm
QCOM
$170B
| $5.08M | 0.16% |
68,416
+6,050
| +10% | +$443K |
|
130
BP
BP
$110B
| $5.06M | 0.16% |
160,040
+32,704
| +26% | +$1.1M |
|
131
Gilead Sciences
GILD
$165B
| $5.04M | 0.16% |
53,504
+7,561
| +16% | +$782K |
|
132
iShares North American Natural Resources ETF
IGE
$778M
| $5.01M | 0.16% |
130,640
+15,306
| +13% | +$620K |
|
133
Visa
V
$675B
| $4.89M | 0.15% |
74,648
-392
| -0.5% | -$23.6K |
|
134
iShares Russell 3000 ETF
IWV
$20.4B
| $4.83M | 0.15% |
39,513
+11,227
| +40% | +$1.34M |
|
135
WisdomTree US LargeCap Dividend Fund
DLN
$6.4B
| $4.83M | 0.15% |
130,122
+4,478
| +4% | +$163K |
|
136
Oracle
ORCL
$435B
| $4.75M | 0.15% |
105,638
+15,038
| +17% | +$612K |
|
137
Boeing
BA
$184B
| $4.74M | 0.15% |
36,483
+282
| +0.8% | +$35.8K |
|
138
State Street SPDR S&P International Small Cap ETF
GWX
$914M
| $4.72M | 0.15% |
172,806
+5,447
| +3% | +$168K |
|
139
iShares Russell 2000 Value ETF
IWN
$14.5B
| $4.71M | 0.15% |
46,280
+1,045
| +2% | +$102K |
|
140
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $4.63M | 0.14% |
62,726
+855
| +1% | +$61.4K |
|
141
Truist Financial
TFC
$63.4B
| $4.61M | 0.14% |
118,617
-4,339
| -4% | -$163K |
|
142
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
| $4.6M | 0.14% |
194,541
+13,194
| +7% | +$302K |
|
143
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $4.59M | 0.14% |
98,564
+18,118
| +23% | +$819K |
|
|
DD
144
DELISTED
Du Pont De Nemours E I
DD
| $4.48M | 0.14% |
63,824
+2,357
| +4% | +$158K |
|
145
UnitedHealth
UNH
$371B
| $4.47M | 0.14% |
44,239
+6,795
| +18% | +$644K |
|
146
WisdomTree International Equity Fund
DWM
$692M
| $4.45M | 0.14% |
89,661
+4,482
| +5% | +$228K |
|
147
General Mills
GIS
$19.9B
| $4.41M | 0.14% |
82,727
-1,733
| -2% | -$89.6K |
|
148
CVS Health
CVS
$122B
| $4.38M | 0.14% |
45,443
+4,194
| +10% | +$370K |
|
|
AMJ
149
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $4.36M | 0.13% |
94,784
-10,826
| -10% | -$529K |
|
150
WisdomTree Japan Hedged Equity Fund
DXJ
$7.43B
| $4.34M | 0.13% |
88,247
+12,061
| +16% | +$630K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Cambridge Investment Research Advisors held 1,571 positions worth $3.23B, down 4.8% from $3.39B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors withdrew a net $213M in Q4 2014, closing 203 positions and reducing 485 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5.3% of assets, up from 4.9% a quarter earlier, followed by Technology and Energy.
Against the trend, Cambridge Investment Research Advisors opened a new position in Vanguard Long-Term Treasury ETF worth $1.5M.
- Cambridge Investment Research Advisors's largest Q4 2014 buy was Vanguard Long-Term Treasury ETF: 19,313 shares worth $1.5M.
- Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q4 2014, an estimated $38.9M increase.
- Cambridge Investment Research Advisors's biggest Q4 2014 reduction was Barclays Bank Plc, cutting an estimated $45.7M.
- Cambridge Investment Research Advisors fully exited Vanguard S&P 500 ETF in Q4 2014, selling an estimated $101M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $3.23B portfolio in Q4 2014.
- Cambridge Investment Research Advisors opened 110 new positions and closed 203 in Q4 2014.
- Cambridge Investment Research Advisors's portfolio value fell 4.8% quarter-over-quarter to $3.23B.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2014, filed 6 Feb 2015.